DNA replication is tightly regulated, but paradoxically there is reported to be an excess of MCM DNA replication proteins over the number of replication origins. Here, we show that MCM levels in primary human T cells are induced during the G 0 -G 1 transition and are not in excess in proliferating cells. The level of induction is critical as we show that a 50% reduction leads to increased centromere separation, premature chromatid separation (PCS) and gross chromosomal abnormalities typical of genomic instability syndromes. We investigated the mechanisms involved and show that a reduction in MCM levels causes dose-dependent DNA damage involving activation of ATR & ATM and Chk1 & Chk2. There is increased DNA mis-repair by non-homologous end joining (NHEJ) and both NHEJ and homologous recombination are necessary for Mcm7-depleted cells to progress to metaphase. Therefore, a simple reduction in MCM loading onto DNA, which occurs in cancers as a result of aberrant cell cycle control, is sufficient to cause PCS and gross genomic instability within one cell cycle.
Introduction
Normal DNA replication must be accurate and occur only once per cell cycle. Sites of DNA replication are 'licensed' (Chong and Blow, 1996) by binding the origin recognition complex that recruits MCM proteins (Mcm2-7), which are conserved from yeast to human beings (Bell and Dutta, 2002) . In human cells undergoing a normal mitotic cell cycle, once a replication origin has fired, re-replication is prevented until the next cycle (Blow and Dutta, 2005; Mailand and Diffley, 2005) . The consequences of triggering re-replication in the same cell cycle are a change in ploidy or potentially abnormal chromosomes.
Genome instability is a hallmark of cancer . A cell is most vulnerable to genomic instability as DNA is replicated in S-phase and then as chromosomes segregate during mitosis. The expression of MCM proteins is abnormal in cancer cells, and anti-MCM antibodies can be used to identify proliferating cells in many cancers (Williams and Stoeber, 2007) . Such abnormal expression is probably a consequence of abnormalities in oncogenes and/or tumour suppressor genes that abrogate cell cycle checkpoints and lead to unscheduled entry into the cell cycle. Expression of nuclear cyclin D1 leads to an increase in Cdt1 expression, increased MCM loading, re-replication and genomic instability (Aggarwal et al., 2007) . In contrast, prevention of pre-replication complex formation in yeast by the induction of increased G 1 -dependent cdk activity induces genomic instability (Tanaka and Diffley, 2002) . In Xenopus laevis egg extracts, over-expression of cyclin E-cdk2 prevents DNA replication initiation by abrogating the binding of Mcm3 to chromatin (Hua et al., 1997) . Cyclin E is also deregulated in many human cancers and the loading of MCM proteins onto chromatin is reduced in these cells (Ekholm-Reed et al., 2004) . However, in Xenopus and human cancer cell lines (for example, HeLa), there is a 420-fold excess of MCM proteins over replication origins (Bell and Dutta, 2002; Hyrien et al., 2003; Blow and Dutta, 2005) . Therefore, a reduction in MCM levels would not be expected to have a profound effect on DNA replication.
In the normal state, most T cells in human peripheral blood are quiescent (G 0 ) and they do not have many of the proteins necessary for cell cycle mechanisms and their control, including proteins required for DNA replication. These proteins are synthesized in response to mitogenic stimulation as cells progress from G 0 through G 1 for the first time (Lea et al., 2003) . Quiescent cells in the body have low levels of MCM proteins compared with proliferating cells (Stoeber et al., 2001; Supplementary Figure S1) , and recently, we identified Mcm7 in a mass spectrometry screen of proteins in human primary T cells that are induced and become bound to chromatin during the G 0 -G 1 transition (Orr et al., in preparation). Thus, we investigated the importance of controlling the precise levels of MCM induction as primary human T cells enter the cell cycle for the first time.
Results
Mcm7 is up-regulated during the G 0 -G 1 transition Non-activated, quiescent human T cells from the peripheral blood of normal donors were stimulated with CD3/CD28 beads. Mcm7 is present at a very low level in quiescent T cells and is induced in mid/late G 1 (16 h). Mcm7 is induced with the same kinetics when the cells are induced with PMA/ionomycin, and gene expression array analyses show that mRNA encoding Mcm7 is induced fourfold by late G 1 (not shown). Analysis of T cells transiently stimulated before and after the G 0 -G 1 commitment point that we described earlier (Lea et al., 2003) shows that Mcm7 is only induced in T cells that are committed to entering the cell cycle ( Figure 1a ). Mcm2-6 are present in G 0 and are also induced as cells progress through late G 1 , albeit with different kinetics (Supplementary Figure S3A) .
Transcription can only occur where there is an open chromatin conformation, which is maintained by epigenetic modifications of histones, such as histone H3 acetylation (H3Ac). H3Ac frequently occurs at the transcriptional start site of inducible genes in quiescent T cells before cell stimulation and gene induction (Smith et al., 2009) , 'priming' gene promoters for transcription factor activation. This study showed that H3Ac priming occurs at the MCM3 transcriptional start site. Given that Mcm7 is induced highly in G 1 from a low/ undetectable level in G 0 , we determined whether the same was true for the MCM7 promoter. The minimal MCM7 promoter contains E2F sites (Suzuki et al., 1998) , and transfection of E2F-1 induces mRNA encoding Mcm7 (and Mcm5 and 6) (Ohtani et al., 1999; Bruemmer et al., 2003) . ChIP analysis of H3Ac across the E2F sites in the MCM7 promoter shows that this positive epigenetic mark is at a low level in G 0 and is induced significantly during the G 0 -G 1 transition (Figure 1b) . E2F-1 is not expressed in quiescent T cells, but is induced in mid-G 1 (Lea et al., 2003) and ChIP analysis shows that it then binds to the MCM7 promoter ( Figure 1c) . Thus, the MCM7 promoter is not 'primed' in G 0 and is epigenetically remodelled before E2F-1 binding and gene activation.
Primary T cells have normal cell cycle controls and DNA damage responses (Gaymes et al., 2002a; Lea et al., 2003) and respond to the DNA cross-linking agent . Non-activated human primary quiescent T cells were isolated from peripheral blood by negative selection. The cells were stimulated continuously with anti-CD3/CD28 and samples were taken for western blotting during the transitions from G 0 -G 1 -S-phase (0-40 h). Cells were also stimulated transiently with anti-CD3/CD28 before (1 or 2 h) and after (8 h) the G 0 -G 1 CP (Lea et al., 2003) and samples were taken at 24 or 40 h. The expression of Mcm7 was determined by western blotting. Phosphorylation of pRb at S 807/811 and expression of MAPK were used as controls for cell cycle entry and as loading controls, respectively. Representative of n ¼ 6 time-courses and n ¼ 3 CP experiments. (b) H3Ac in MCM7 in G 0 and G 1 . Mono-nucleosomes were isolated from quiescent T cells and 72 h post-stimulation with PMA/ionomycin (G 1 ). The presence of nucleosomes containing H3Ac at the E2F sites in the MCM7 promoter was determined by native ChIP-PCR. IgG: control ChIP. Input: PCR with total nucleosomal DNA. Representative of n ¼ 3 individual T-cell isolates. Figure  S4) . Thus, we used primary human T cells to investigate the consequences of reducing the levels of MCM proteins as these quiescent cells entered and progressed through the first cell cycle.
Quantifying the number of MCM proteins in T cells
We determined the number of molecules of MCM proteins expressed in primary T cells by comparing the expression of Mcm2 in T cells stimulated for 72 h with PMA/ionomycin against a titration of a recombinant N-terminal Mcm2 fragment (Figure 1d ; Supplementary Figure S2 ). We found that T cells have about 3.5 Â 10 À19 mol of Mcm2 per cell, equivalent to 2 Â 10 5 molecules per cell. PMA/ionomycin stimulates all cells, but at 72 h not all the T cells have entered S-phase (Lea et al., 2003) . However, the same Mcm2 levels occur in T cells proliferating for 3 days in IL-2 (not shown Figure S3B) . Therefore, the reduction in Mcm7 is unlikely to be due to off-target effects. Transfection with Mcm7 siRNA did not affect the overall levels of expression of Mcm2-6, but did reduce chromatin binding of all MCM proteins as cells become licensed in late G 1 (Figure 2b ). This is consistent with the fact that MCM proteins bind DNA as a complex and reducing one MCM protein would be expected to reduce the binding of all the others. The Cdc6 protein also forms part of the DNA replication origin licensing complex, but binds DNA before MCM proteins (Bell and Dutta, 2002) . Consistent with this, the level of chromatin-bound Cdc6 was not affected by reducing Mcm7 (Figure 2a ).
Depletion of Mcm7 leads to a prolonged G 2 phase and induces DNA damage responses An earlier study showed that X. laevis cells still enter S-phase with 5-10% normal levels of MCM proteins (Blow and Dutta, 2005) . However, X. laevis have a 420-fold excess of MCM proteins over replication origins. In contrast, reducing Mcm7 to o5% of normal levels in primary T cells, in which we have shown that MCM proteins are not in excess, would be expected to severely inhibit proliferation. We reduced Mcm7 to o5% of the normal levels in primary T cells with siRNA, and rather than being inhibited in G 1 , these cells progressed from G 0 -G 1 -S-phase when stimulated with PMA/ionomycin. The proportion of cells in S-phase was reduced, but there was a significant increase in the numbers of cells in G 2 /M as compared with control siRNAtransfected cells ( Figure 2c ; S-phase: Po0.001; G 2 /M: Po0.02; paired t-test). In agreement with the flow cytometry data shown in Figure 2c , BrdU incorporation in control-siRNA-transfected cells was 55 ± 2.5% greater than in cells transfected with Mcm7 siRNA (ELISA assays on replicate experiments with n ¼ 3 T-cell isolates; Po0.0001).
Next, we determined whether the G 2 /M block was in G 2 or M by analysing the presence of phospho-histone H3-S 10 , which occurs in mitosis (Hans and Dimitrov, 2001 ). Mcm7 depletion did not increase the proportion of cells containing phospho-histone H3-S 10 as compared with cells transfected with control siRNA (Figure 2d ). Therefore, the cell cycle block is not in mitosis, rather these data indicate an increase in the number of cells in G 2 .
An increase in cells in G 2 is probably the result of a prolongation of G 2 , consistent with a DNA damage response caused by DNA replication fork stalling. Indeed, reducing Mcm7 to 2-5% of normal levels resulted in cells with foci of phospho-gH2AX, indicative of DNA doublestrand breaks, and foci of phospho-ATM, -ATR, -Chk1 and -Chk2 (Figure 3a Figure S5B) . Thus, the induction of DNA damage is likely to be due to a decrease in binding the MCM complex to DNA rather than because of the reduction of a particular MCM protein.
Depletion of Mcm7 leads to gross chromosomal abnormalities
In spite of causing DNA damage, reducing Mcm7 did not cause significant apoptosis, as judged by sub-G 1 staining and PARP cleavage (Figure 2c ; Supplementary Figure S5C ). We used standard cytogenetic analyses to investigate whether this led to chromosomal changes. Our data show that Mcm7 depletion causes (Cell Signalling) and analysing by flow cytometry. Cells were also labelled with propidium iodide to determine DNA content. Cells that had 4n DNA content and were positive for phospho-Histone H3-S 10 staining were counted as mitotic.
chromosomal abnormalities of varying severity. Metaphase spreads showed individual cells in the population that had few abnormalities, such as chromosome fragments and additions (for example add(9)), whereas others were grossly abnormal and contained tri-radial figures, terminal fragments, chromatid breaks and asymmetric interchanges (Figure 4Af ). Each metaphase observed comes from a single cell and there were no multiple metaphases in any of the samples analysed that had exactly the same pattern of abnormalities. The proportion of abnormal cells increased as Mcm7 levels were decreased (Figures 4Ab-e ) and abnormalities were detectable even when the level of chromosome-bound Mcm7 was reduced by only 50% (Figure 4Ab ). Transfection with the four individual siRNAs also led to gross chromosomal abnormalities (Supplementary Table S3 ), indicating that this is not an off-target effect. The percentage of cells with chromosomal abnormalities also increased when Mcm4 was reduced (control siRNA 5.25%, Mcm4 siRNA 19.75%; mean of n ¼ 2 experiments), indicating that such gross chromosomal abnormalities are not specifically due to reduction of Mcm7. Similar chromosomal abnormalities also occur when cells from patients with genomic instability syndromes such as Fanconi anaemia or Bloom's syndrome are subjected to a mild replication stress (Howell and Taylor, 1992 Figure  S5D) , indicating that the chromosomal abnormalities seen in Mcm7-depleted cells are unlikely to be due to aberrant recruitment of these pathways.
The cytogenetic analyses of chromosomal abnormalities caused by Mcm7 depletion do not allow detailed characterization of chromosomal rearrangements. Therefore, we carried out more detailed analyses of the chromosomal abnormalities caused by reduction in Mcm7 using M-FISH ( Figure 4B ). Depletion of Mcm7 causes chromosomal translocations, breaks, deletions, fragments as well as loss and gain of whole chromosomes (Figures 4Bb and c ; quantified in Figure 4C ). There were significantly more abnormalities per cell as compared with cells transfected with control siRNA (2.45 ± 0.05 vs 0.22 ± 0.07, mean ± s.e.m.; Po3.3 Â 10
À12
). Such abnormalities were also evident in slides stained with centromere probes (Figures 4Dd-f) . Chromosomal translocations, losses of parts of chromosomes as well as loss and gain of whole chromosomes can occur in the same cell (Figure 4Bc) . Thus, simply depleting Mcm7 is sufficient to account for translocations as well as changes in ploidy and these are not mutually exclusive events. We did not detect a gross poly-ploidy in the population of cells depleted of Mcm7, as judged by flow cytometric analyses of DNA content (Figure 2c ) or multi-nucleated cells by microscopic examination of MGG-stained slides (not shown). However, we noted small numbers of individual DAPIstained cells that were poly-ploid (o1%; Figure 4Df ).
Depletion of Mcm7 causes premature chromatid separation
In addition to causing chromosomal abnormalities, depletion of Mcm7 also causes premature chromatid separation (PCS) (Kajii et al., 1998) , evidenced by partially separated chromosomes in some metaphase spreads ( Figure 4A , compare panel a with e). To quantify PCS, we stained metaphase spreads with a centromere-specific probe and quantified the distances between centromeres of sister chromatids ( Figure 4D Table S3 ). These abnormalities are reminiscent of a failure to secure newly synthesized chromatin to the parental template, which normally occurs in S-phase during DNA replication (Nasmyth and Haering, 2005; Moldovan et al., 2006) .
Both NHEJ and HR are required for Mcm7-depleted cells to enter mitosis
We investigated the mechanisms required for chromosomal abnormalities to occur. DNA damage during S-phase is thought to be repaired predominantly by HR (Arnaudeau et al., 2001) . Consistent with this, we detected RAD51-foci in cells depleted of Mcm7 or Mcm4 (Figure 3; Supplementary Figure S5A) . However, non-homologous end joining (NHEJ) has also been shown to be involved in repairing double-strand breaks caused by stalled replication forks (Lundin et al., 2002) . We investigated whether NHEJ was also induced by Mcm7 depletion by using two cell-free assays that we employed earlier in studies of chromosome instability syndromes and leukaemias (Gaymes et al., 2002a, b) . In vitro end ligation and plasmid reactivation assays show the formation of dimers in control siRNAtransfected cells because of endogenous levels of NHEJ activity. Depletion of Mcm7 led to an increase in endligation activity, shown by an increase in further ligation events, which form trimers and multimers (Figure 5a ). The total amount of ligated products was greater in the Mcm7-depleted cells than in controls (Figure 5b ) and the frequency of mis-repair was also increased (Figure 5c Figures S2 and S5E ). Mis-repair caused by depleting Mcm7 led to an increase in large deletions (Figures 5c and d) . Inhibition of the NHEJ-protein Ku-70, but not the HR-protein RAD51, reduced the mis-repair frequency and the number of large deletions to near normal levels (Figures 6a and b) . Anti-Ku-86 had a similar effect to Ku-70 and this was abrogated by pre-incubating the antibody with its cognate peptide (Figures 6c and d ). Depleting XRCC4 with siRNA reduced the repair to zero. These data are consistent with the acquisition of DNA abnormalities because of increased NHEJ mis-repair activity in Mcm7-depleted cells.
Mcm7 depletion (Supplementary
To determine whether we could detect chromosomal abnormalities caused by depleting Mcm7 if NHEJ or HR were compromised, we reduced Mcm7 to cause DNA damage and also depleted XRCC4 or Rad51 by co-transfecting both Mcm7 and either XRCC4 or Rad51 siRNAs (Supplementary Figure S5E) . No metaphases were obtained when both Mcm7 and XRCC4 or Mcm7 and Rad51 were depleted, indicating that both NHEJ and HR pathways are necessary for cells to progress through to metaphase when Mcm7 is depleted. These data are consistent with earlier reports that HR and NHEJ repair DNA damage caused by replication fork stalling (Arnaudeau et al., 2001; Lundin et al., 2002) , indicating that both pathways are necessary for cells with reduced Mcm7 levels to progress from S-phase through G 2 into M-phase. Flow cytometry of DNA and protein content showed that cells in which Mcm7 and XRCC4 or Rad 51 were depleted were still able to progress through the cell cycle to G 2 /M. Although there was a reduction in the proportion of cells in G 2 /M in some experiments, this was not statistically significant. Note that depleting XRCC4 or Rad51 alone had no significant effect on cell cycle progression (not shown), indicating that down-regulating NHEJ or HR pathways alone is not sufficient to prevent progression through S-phase to G 2 /M in the absence of DNA damage caused by depleting Mcm7.
Discussion
In this study, we have shown that the level of induction of Mcm7, and hence the MCM helicase during the G 0 to G 1 transition, is critical to maintain genome stability in primary human T cells. Even a 50% reduction in Mcm7 levels leads to DNA damage, repair by HR and NHEJ pathways, PCS and leads to severe chromosomal abnormalities typical of genomic instability syndromes.
In yeast and X. laevis embryos, MCM proteins are in excess of replication origins, and reducing MCM loading using a tsMcm2 mutant causes DNA damage, chromosomal loss and mitotic recombination (Lei et al., 1996; Liang et al., 1999) . In other studies, reducing Mcm4 caused endoreduplication (Coxon et al., 1992) and reduction of Mcm2, Mcm4, Mcm6 or Mcm7 caused a block in late S-phase similar to that caused by replication fork collapse, DNA damage and reduced viability (Bailis et al., 2008) . This study also showed that the MCM complex interacts with the HR protein Rhp51(Rad51) and that loss of HR leads to chromosome mis-segregation after replication fork collapse. The direct interaction of MCM proteins with Rad51 and Rad52 proteins has also been shown to occur in the human cell line HeLa (Shukla et al., 2005) . Reducing Mcm4 or Mcm7 in HeLa cells caused DNA damage, Rad51 foci, increased apoptosis and a higher proportion of multi-nucleated cells or cells with micronuclei (Bailis et al., 2008) . Tsao et al. (2004) showed that Mcm7 also interacts with Rad17 in human cancer cell lines, including HeLa and that this interaction is required for DNA damage responses triggered by UV irradiation or Aphidicolin. Other studies have shown that the response of human transformed cell lines to a reduction in MCM proteins differs from that of untransformed cell lines. For example, reducing MCM loading in various cancer cell lines impaired replication, caused S-phase arrest and apoptosis, whereas normal cell lines arrested mainly in G 1 (Shreeram et al., 2002; Feng et al., 2003; EkholmReed et al., 2004) . Depletion of Mcm7, but not other MCM proteins, also caused S-phase arrest in Drosophila S2 cells (Crevel et al., 2007) . The S-phase arrest is consistent with stalling replication forks, causing engagement of the S-phase DNA damage checkpoint. It has been suggested that the excess of MCM proteins over the replication origins that normally fire may be due to the fact that only some of the possible origins actually fire (Hyrien et al., 2003) . Indeed, the spacing between active replication origins in human U2OS cells decreases significantly in response to replication stress. This reduction did not occur when MCM levels were decreased, suggesting that dormant origins that are suppressed during a normal S-phase can be activated by the 'excess' MCM proteins after replication fork inhibition, thus allowing completion of DNA replication (Ge et al., 2007) .
The studies described above have investigated the requirement for MCM proteins in proliferating cells. Earlier work has shown that the levels of MCM proteins reduce significantly in cells exiting the cell cycle (Stoeber et al., 2001) , and it has been proposed that the presence of licensed origins distinguishes cells in G 1 from G 0 (Blow and Hodgson, 2002) . In agreement, our data show that human T cells in G 0 have low levels of most MCM proteins and in particular significantly reduced levels of Mcm7. Mcm7 mRNA and protein are induced as T cells enter G 1 and the levels of all the MCM proteins are significantly higher in continuously proliferating cells. Chromatin has to be in an open conformation to allow transcription factor binding. Such chromatin remodelling is regulated by histone epigenetic modifications. We show elsewhere that, on average, epigenetic signatures at transcriptional start sites, such as H3Ac, are already set at many inducible genes in quiescent T cells before cell stimulation (Smith et al., 2009) . However, we noted in that study that H3Ac signatures are up-regulated in specific regions of some genes, such as IRF4 and RUNX3 when they are induced in G 1 . This also occurs for MCM3 downstream of the transcriptional start site. The minimal MCM7 promoter contains E2F sites and E2F-1 can induce mRNA encoding several MCM proteins, including Mcm7 (Suzuki et al., 1998; Ohtani et al., 1999; Bruemmer et al., 2003) . E2F-1 is not present in T cells in G 0 ; it is induced in G 1 once cells have passed the G 0 -G 1 commitment point. The ChIP experiments presented here show that E2F-1 binds directly to the MCM7 promoter in G 1 , although we cannot rule out that other E2Fs also bind at these sites. Our study showed that in MCM3, the E2F site ( þ 38; Taubert et al., 2004) is primed in G 0 before cell stimulation, in which it already has a high level of H3Ac. In this context, it may be significant that Mcm3 is already expressed in G 0 . In contrast, we show that Mcm7 is present at a very low level in G 0 . The E2F sites in the MCM7 promoter are not primed and H3Ac at this position is induced in cells stimulated to enter G 1 . These data suggest that MCM7 is epigenetically suppressed in G 0 and is regulated by chromatin remodelling, which subsequently allows transcription factor (E2F) access and gene induction.
We also quantified the levels of MCM expression in primary human T cells that had been stimulated to enter the cell cycle. Our data show that there are 2 Â 10 In our study, we investigated the requirement for induction of Mcm7 and Mcm4 during the G 0 -G 1 transition and to what extent the levels of expression are important for subsequent progression through the cell cycle. In contrast to the cell lines investigated in other studies, a reduction in MCM loading in primary human T cells does not cause cell cycle arrest in G 1 or apoptosis, but induces DNA damage, DNA repair responses (NHEJ and HR) and leads to chromosomal abnormalities. We observed that chromosomal translocations, deletions as well as loss and gain of individual chromosomes can occur separately or all in the same cell and occur within one cell cycle. Our findings are consistent with the fact that replication defects induced by a variety of experimental methods can cause genome instability (Flores-Rozas and Kolodner, 2000; Kolodner et al., 2002) . As primary human T cells do not have an excess of MCM proteins relative to replication origins, a small decrease in the levels of induction of MCM proteins as cells progress from G 0 through G 1 would have severe consequences. If this occurs in stem cells in vivo, it would predispose the cell to further abnormalities, which would accumulate over several replicative cycles and could result in cancer. MCM binding to DNA is decreased by aberrant G 1 CDK activity or overexpression of cyclin E, which occur in many cancers, including breast cancer and acute myeloid leukaemia M4/M5. Furthermore, mice with lower Mcm2 levels develop B-and T-cell lymphomas (Pruitt et al., 2007) and chemically induced breast cancers in mice were caused by MCM4 mutation (Shima et al., 2007) .
Our study also shows that depletion of Mcm7 causes PCS with a doubling of distances between the centromeres of sister chromatids consistent with a failure to secure sister chromatids during S-phase. Studies on yeast show that replication fork passage is required for establishment of cohesion (Lengronne et al., 2006; Shimada and Gasser, 2007) and MCM proteins are required for establishment of cohesion in X. laevis egg extracts (Gillespie and Hirano, 2004; Takahashi et al., 2004) . Taken together, these data suggest that replication fork collapse caused by reducing MCM levels would be expected to reduce chromatid cohesion. The consequences of reduced cohesion are severe in vivo and patients with PCS trait have chromosomal abnormalities, exhibit developmental abnormalities and have a high risk of malignancy (Kajii et al., 1998 (Kajii et al., , 2001 .
We also show that reducing Mcm7 levels results in increased NHEJ activity, and cells with reduced MCM levels do not reach metaphase if both NHEJ and HR pathways are also compromised. NHEJ is a more errorprone pathway than HR and we showed earlier that NHEJ mis-repair is increased in Bloom's chromosomal instability syndrome, as well as in the myelodysplastic syndromes (pre-leukaemic conditions) and in myeloid leukaemias (Gaymes et al., 2002a, b) . The data here show that the induction of normal levels of MCM proteins during the G 0 -G 1 transition are critical in maintaining genome stability and a small reduction in MCM levels is sufficient to cause DNA mis-repair, PCS and gross chromosomal abnormalities.
Materials and methods

Routine methods
T-cell isolation, western blotting, immunofluorescence, ChIP and chromosomal analyses were as described earlier (Supplementary Information).
siRNA transfection Pools of four siRNA to targets described in the text or control siRNA (Smartpool, Dharmacon), or each of the four individual siRNA were transfected into quiescent T cells by nucleofection (Amaxa, Lonza, Berkshire, UK) (siRNA sequences are in Supplementary Information). Cells transfected with siRNA were cultured overnight without stimulus to recover, stimulated with PMA/ ionomycin and samples were typically taken 72 h later.
